ANXA1 and acute myeloid leukemia: Thus, our present results provide new insights into the development of novel AML drugs, such as stapled peptides, peptidomimetics, small molecules, and antibodies, to treat AML based on the direct interaction of ANXA1 and Notch1 on the cell membrane.